FAA Embraces AI to Transform Air Traffic Control Safety
June 22, 2026
January 30, 2025
The FDA has approved Vertex Pharmaceuticals' non-opioid painkiller Journavx, marking the first new type of pain medicine approved in decades and offering an alternative to opioids without the risk of addiction.
January 30, 2025
A recent study published in the Canadian Medical Association Journal explores the wide-ranging health benefits of physical activity for older adults, highlighting how exercise reduces mortality, improves cognitive function, and enhances quality of life — yet remains widely underprescribed in clinical care.
November 19, 2024
A clinical trial testing muvalaplin, a novel oral medication, demonstrated safe and effective reduction of high lipoprotein(a) levels by up to 85.5%, according to late-breaking science presented at the American Heart Association's Scientific Sessions 2024.